Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

June 28, 2021

Study Completion Date

June 28, 2021

Conditions
Osteonecrosis
Interventions
OTHER

Lactated Ringers

Approximately 5 mls of lactated ringers will be injected after decompression into the hip that does not receive adipose derived regenerative cells.

DEVICE

The Celution 800/GP System (Cytori Therapeutics)

The Celution 800/GP System will be used for the preparation of adipose derived regenerative cells from lipoaspirate. The adipose derived regenerative cells will then be transplanted into the hip, post decompression.

BIOLOGICAL

Adipose Derived Regenerative Cells (ADRC)

Subjects in this arm will have Adipose Derived Regenerative Cells (ADRC)harvested through autologous liposuction and processed outside the body using The Celution 800/GP System (Cytori Therapeutics) before having approximately 5 mls. of ADRCs transplanted into the femoral head after standard of care hip decompression.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER